Alexion to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology

BOSTON--(BUSINESS WIRE)--Sep. 25, 2018-- Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Leerink Partners Roundtable Series: Rare Disease & Oncology in New York, NY on Tuesday, October 2, 2018 at 10 a.m., EDT.

An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexion.com. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

[ALXN-G]

View source version on businesswire.com: https://www.businesswire.com/news/home/20180925006098/en/

Source: Alexion Pharmaceuticals

Alexion Pharmaceuticals
Investors
Susan Altschuller, Ph.D.
Vice President, Investor Relations
(475) 230-3534